Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Volatile breath biomarkers for patient monitoring during haemodialysis.

Goerl T, Kischkel S, Sawacki A, Fuchs P, Miekisch W, Schubert JK.

J Breath Res. 2013 Mar;7(1):017116. doi: 10.1088/1752-7155/7/1/017116. Epub 2013 Feb 27.

PMID:
23446309
2.

Monitoring of oxidative and metabolic stress during cardiac surgery by means of breath biomarkers: an observational study.

Pabst F, Miekisch W, Fuchs P, Kischkel S, Schubert JK.

J Cardiothorac Surg. 2007 Sep 18;2:37.

3.

Breath analysis in patients with end-stage renal disease: effect of haemodialysis.

Rolla G, Bruno M, Bommarito L, Heffler E, Ferrero N, Petrarulo M, Bagnis C, Bugiani M, Guida G.

Eur J Clin Invest. 2008 Oct;38(10):728-33. doi: 10.1111/j.1365-2362.2008.02016.x.

PMID:
18837798
4.

Elective haemodialysis increases exhaled isoprene.

Lirk P, Bodrogi F, Raifer H, Greiner K, Ulmer H, Rieder J.

Nephrol Dial Transplant. 2003 May;18(5):937-41.

5.

Effect of hemodialysis and diet on the exhaled breath methanol concentration in patients with ESRD.

Lee HJ, Pahl MV, Vaziri ND, Blake DR.

J Ren Nutr. 2012 May;22(3):357-64. doi: 10.1053/j.jrn.2011.07.003. Epub 2011 Nov 18.

PMID:
22100775
6.

Impact of hemodialysis on exhaled volatile organic compounds in end-stage renal disease: a pilot study.

Assady S, Marom O, Hemli M, Ionescu R, Jeries R, Tisch U, Abassi Z, Haick H.

Nanomedicine (Lond). 2014 May;9(7):1035-45. doi: 10.2217/nnm.13.85. Epub 2013 Sep 25.

PMID:
24066923
7.

Blood and breath profiles of volatile organic compounds in patients with end-stage renal disease.

Mochalski P, King J, Haas M, Unterkofler K, Amann A, Mayer G.

BMC Nephrol. 2014 Mar 8;15:43. doi: 10.1186/1471-2369-15-43.

8.

Increased hydrogen peroxide in the exhaled breath of uraemic patients unaffected by haemodialysis.

Rysz J, Kasielski M, Apanasiewicz J, Król M, Woźnicki A, Luciak M, Nowak D.

Nephrol Dial Transplant. 2004 Jan;19(1):158-63.

9.

Noninvasive detection of lung cancer by analysis of exhaled breath.

Bajtarevic A, Ager C, Pienz M, Klieber M, Schwarz K, Ligor M, Ligor T, Filipiak W, Denz H, Fiegl M, Hilbe W, Weiss W, Lukas P, Jamnig H, Hackl M, Haidenberger A, Buszewski B, Miekisch W, Schubert J, Amann A.

BMC Cancer. 2009 Sep 29;9:348. doi: 10.1186/1471-2407-9-348.

10.

Onset, time course, and persistence of increased haemodialysis-induced breath isoprene emission.

Trovarelli G, Brunori F, De Medio GE, Timio M, Lippi G, Pelli MA, Capodicasa E.

Nephron. 2001 May;88(1):44-7.

PMID:
11340350
11.

Volatile organic compounds in uremia.

Pagonas N, Vautz W, Seifert L, Slodzinski R, Jankowski J, Zidek W, Westhoff TH.

PLoS One. 2012;7(9):e46258. doi: 10.1371/journal.pone.0046258. Epub 2012 Sep 25.

12.

Impact of inspired substance concentrations on the results of breath analysis in mechanically ventilated patients.

Schubert JK, Miekisch W, Birken T, Geiger K, Nöldge-Schomburg GF.

Biomarkers. 2005 Mar-Jun;10(2-3):138-52.

PMID:
16076729
13.

Staff-assisted nursing home haemodialysis: patient characteristics and outcomes.

Reddy NC, Korbet SM, Wozniak JA, Floramo SL, Lewis EJ.

Nephrol Dial Transplant. 2007 May;22(5):1399-406. Epub 2007 Jan 27.

14.

Immediate effects of breath holding maneuvers onto composition of exhaled breath.

Sukul P, Trefz P, Schubert JK, Miekisch W.

J Breath Res. 2014 Sep;8(3):037102. doi: 10.1088/1752-7155/8/3/037102. Epub 2014 Sep 4.

PMID:
25189647
15.

Monitoring breath during oral glucose tolerance tests.

Ghimenti S, Tabucchi S, Lomonaco T, Di Francesco F, Fuoco R, Onor M, Lenzi S, Trivella MG.

J Breath Res. 2013 Mar;7(1):017115. doi: 10.1088/1752-7155/7/1/017115. Epub 2013 Feb 27.

PMID:
23446273
16.

Analysis of breath volatile organic compounds as a noninvasive tool to diagnose nonalcoholic fatty liver disease in children.

Alkhouri N, Cikach F, Eng K, Moses J, Patel N, Yan C, Hanouneh I, Grove D, Lopez R, Dweik R.

Eur J Gastroenterol Hepatol. 2014 Jan;26(1):82-7. doi: 10.1097/MEG.0b013e3283650669.

PMID:
24284369
17.

[New opportunities of renal diseases diagnostics using gas chromatography].

Grabowska-Polanowska B, Faber J, Skowron M, Miarka P, Pietrzycka A, Zagrodzki P, Sliwka I, Sutowicz W, Stepniewski M.

Przegl Lek. 2012;69(3):91-7. Polish.

PMID:
22764649
18.

Electrochemical sensor system for breath analysis of aldehydes, CO and NO.

Obermeier J, Trefz P, Wex K, Sabel B, Schubert JK, Miekisch W.

J Breath Res. 2015 Mar 9;9(1):016008. doi: 10.1088/1752-7155/9/1/016008.

PMID:
25749754
19.

Volatile organic compounds in the exhaled breath of young patients with cystic fibrosis.

Barker M, Hengst M, Schmid J, Buers HJ, Mittermaier B, Klemp D, Koppmann R.

Eur Respir J. 2006 May;27(5):929-36. Epub 2006 Feb 2.

20.

Volatile alkanes and increased concentrations of isoprene in exhaled air during hemodialysis.

Capodicasa E, Trovarelli G, De Medio GE, Pelli MA, Lippi G, Verdura C, Timio M.

Nephron. 1999;82(4):331-7.

PMID:
10450035
Items per page

Supplemental Content

Write to the Help Desk